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2002, detailed demographic and survival information were obtained. A 
total of 18346 (70%)documented smokers including the former and the 
current and 7755(30%) documented never smokers with non-small cell 
lung cancer were studied. Among them, the 2546 patients with stage IV 
lung adenocarcinoma were studied to examine the relationship between 
the smoking status or the gender and the chemotherapy effect. Multi-
variate analysis was performed using the Cox regression method.
Results: There was an increased percentage of female subjects (72%) 
in the never smokers, and an increased percentage of male subjects 
(90%) in the smokers. The never smokers had lower performance 
status (PS) and lower clinical stage than the smokers (p<0.001). There 
was an increased percentage of adenocarcinoma (83%) in the never 
smokers. Multivariate analysis for all the patients demonstrated that 
the lower clinical stage, the lower PS, younger age, female and never 
smoking was an independent good prognostic factor The hazard ratio 
(HR) and its 95%CI was 3.73(3.58-3.88),2.69(2.59-2.79), 1.21(1.17-
1.25), 1.15(1.09-1.20), and 1.08(1.04-1.14), respectively. Multivariate 
analysis for the stage IV adenocarcinoma also showed that the lower 
PS, female and never smoking was an independent good prognostic 
factor. The HR and its 95%CI was 2.37(2.15-2.61), 1.35(1.19-1.52) 
and 1.17(1.04-1.32) respectively. In the treatment of chemotherapy for 
the stage IV adenocarcinoma patients, the never smokers had higher 
disease control rates (CR+PR+SD) than the smokers (p=0.08) and the 
females had higher response rates (CR+PR) than the males (p=0.02).
Conclusions: The never smokers and females with non-small cell lung 
cancer were found to have a distinct and improved clinical outcome.
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Background: In order to describe the recent lung cancer incidence & 
mortality in Taiwan, a Bayesian age-period-cohort (APC) model was 
applied 
Methods: Using the National Cancer Registry data from 1979 to 2002 
(n=91811), data from 1996 to 2002 with age at diagnosis between 20 
to 89 years old were used (n=44139) in view of data completeness 
(survival status & treatment strategies). An autoregressive prior model 
was used to smooth age, period, and cohort effects. Posterior distribu-
tions were derived from 5,000 iterations to draw inferences & 95% 
conﬁdence interval (95%CI). We deﬁned the median iterated value 
as an overall summary data. Age-adjusted standardized mortality & 
incidence rate (ASMR & ASIR, per 100000 person-year) and case 
fatality rate (ASMR/ASIR) were calculated using population in 2002 
as reference. Descriptive analysis was done for periodical treatment 
strategies distribution (operation, chemotherapy, & others) and related 
case fatality rate. 
Results: The mid-term mortality (2 year ASMR) was decreasing for 
male lung cancer patients in Taiwan since around year 2000 (from 48 
in 2000 to 45 in 2002), which was mainly due to decrease in incidence 
(ASIR) during this period (from 61 in 2000 to 57 in 2002). As for 
female, the mid-term (2 year) mortality was still slightly increasing 
(from 19 in 1996 to 22 in 2002), which was mainly due to increasing 
incidence (from 24 in 1996 to 29 in 2002). There were small improve-
ment in short term (1 year) case fatality rate, possibly due to Increased 
utilization (about 15~18% increment) of chemotherapy. The improve-
ment ranged from 68% (95%CI: 65-71) in 1997 to 65% (63-68) in 
2002 for male (ﬁg 1, upper) and 63% (59-67) in 1996 to 57% (54-60) 
in 2002 for female (ﬁg 1, lower). However, the mid term (2 year) case 
fatality rate roughly remained the same, especially for male (81% (95% 
CI 78-84) in 1997 to 82% (79-84) in 2002) (ﬁg 1, upper) in contrast to 
female (78%(74-83) in 1997 to 75(72-79) in 2002) (ﬁg 1, lower)
Conclusions: Mid-term mortality was decreasing for male lung cancer 
patients in Taiwan since around year 2000, while it was slightly increas-
ing for female. These changes were mainly due to change in incidence 
during this period. Increased utilization of chemotherapy may lead to 
small improvement in short term instead of mid term case fatality rate.
Figure 1. 1y: one year; 2y: two year; E: estimated case fatality rate; L & H: 95 % 
confidence interval
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Background: Certain racial minorities exhibit poor survival in early 
stage non-small cell lung cancer (NSCLC) in the US and is generally 
attributed to low socioeconomic status (SES). We investigated how the 
role SES may play a role in this disparity in survival.
Methods: We conducted a case-only analysis of the California Cancer 
Registry (CCR) (1989-2003) including descriptive analysis of relevant 
